These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29636104)

  • 1. Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease.
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Ji X; Kong SX; Milinovich A; Weng W; Bauman J; Ganguly R; Burguera B; Kattan MW; Zimmerman RS
    Cardiovasc Diabetol; 2018 Apr; 17(1):54. PubMed ID: 29636104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center.
    Hamid A; Vaduganathan M; Oshunbade AA; Ayyalasomayajula KK; Kalogeropoulos AP; Lien LF; Shafi T; Hall ME; Butler J
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):313-320. PubMed ID: 32569016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cardiovascular medicines in newly treated type 2 diabetes patients: A retrospective cohort study in general practice.
    Grimes RT; Ensor J; Bennett K; Henman MC
    Prim Care Diabetes; 2016 Aug; 10(4):237-43. PubMed ID: 26654852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries.
    Mosenzon O; Alguwaihes A; Leon JLA; Bayram F; Darmon P; Davis TME; Dieuzeide G; Eriksen KT; Hong T; Kaltoft MS; Lengyel C; Rhee NA; Russo GT; Shirabe S; Urbancova K; Vencio S;
    Cardiovasc Diabetol; 2021 Jul; 20(1):154. PubMed ID: 34315481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.
    Eliasson B; Ekelund J; Holmberg CN; Wolden ML; Matthiessen KS; James S
    Eur J Prev Cardiol; 2023 May; 30(7):546-551. PubMed ID: 36567502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020.
    Sherrill CH; Hwang AY
    Ann Pharmacother; 2024 Mar; 58(3):248-254. PubMed ID: 37323006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
    Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
    Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care.
    Emanuel G; Charlton J; Ashworth M; Gulliford MC; Dregan A
    Heart; 2016 Dec; 102(24):1957-1962. PubMed ID: 27534979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England.
    Abner S; Gillies CL; Shabnam S; Zaccardi F; Seidu S; Davies MJ; Adeyemi T; Khunti K; Webb DR
    Cardiovasc Diabetol; 2022 Jan; 21(1):8. PubMed ID: 35012531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAPTURE: A cross-sectional study on the prevalence of cardiovascular disease in adults with type 2 diabetes in Italy.
    Russo GT; Corigliano G; Arturi F; Cavallo MG; Bette C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1195-1201. PubMed ID: 35260306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration.
    Chang LS; Vaduganathan M; Plutzky J; Aroda VR
    Curr Diab Rep; 2019 Dec; 19(12):157. PubMed ID: 31802265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: A national cross sectional study.
    Manski-Nankervis JE; Thuraisingam S; Sluggett JK; Lau P; Blackberry I; Ilomaki J; Furler J; Bell JS
    Prim Care Diabetes; 2019 Apr; 13(2):113-121. PubMed ID: 30262176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade.
    Kocyigit D; Gurses KM; Yalcin MU; Tokgozoglu L
    Endocr Metab Immune Disord Drug Targets; 2017; 17(1):19-31. PubMed ID: 28440199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient healthcare utilization 30 days before and after hospitalization for heart failure in France: Contribution of the national healthcare database (Systèmenationaldesdonnéesdesanté).
    Feldman SF; Lesuffleur T; Olié V; Gastaldi-Ménager C; Juillière Y; Tuppin P
    Arch Cardiovasc Dis; 2020; 113(6-7):401-419. PubMed ID: 32473996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: "INSIST" study.
    Mohammedi K; Fauchier L; Quignot N; Khachatryan A; Banon T; Kapnang R; Kikuchi K; Ren H; Massien C; Vigié L; Larsen S; Sibon I
    Cardiovasc Diabetol; 2024 May; 23(1):183. PubMed ID: 38812009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians.
    Grant RW; Wexler DJ; Ashburner JM; Hong CS; Atlas SJ
    Arch Intern Med; 2012 May; 172(10):821-3. PubMed ID: 22636827
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses.
    Rathmann W; Pscherer S; Konrad M; Kostev K
    Prim Care Diabetes; 2016 Feb; 10(1):36-40. PubMed ID: 25937183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic drug use trends in patients with type 2 diabetes mellitus and chronic kidney disease: A cross-sectional analysis of the National Health and Nutrition Examination Survey.
    Gor D; Gerber BS; Walton SM; Lee TA; Nutescu EA; Touchette DR
    J Diabetes; 2020 May; 12(5):385-395. PubMed ID: 31652390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.